NBIS Down 29% in a Week — Insiders Sold Near the Top

Nebius Group has fallen 29% in the past week to $195.19. The short book — already at 24% of free float — remains entrenched. And the CEO sold $11M of stock on July 1, just days before the sharpest leg of the decline.

Insiders Sold Into Strength

Three executives filed sales on July 1, with the stock at $235.45. CEO Arkady Volozh sold 46,627 shares for $11.0M. Chief Level Officer Andrey Korolenko sold 33,871 shares for $8.0M. CTO Danila Shtan sold 16,937 shares for $4.0M. Combined, those three trades total roughly $23M in a single day. Chairman John Boynton had already sold a further $1.1M across multiple tranches on June 15, when shares were trading above $246.

The 90-day net insider position is a net sale of approximately $144M. There are no purchases in the recent trade log to offset that.

Shorts Are Not Covering

Short interest sits at 24.0% of free float as of July 6. That is up 17.3% over the past month. The short book has remained essentially static despite the stock's sharp move — previous notes flagged the position at 23.8–23.9% of free float as recently as June 30. Shorts held through the stock's bounce to $276 in late June. They are now sitting on a position that has moved substantially in their favour.

Borrow Has Partially Loosened — But Remains Tight

The borrow picture has shifted since the July 3 pulse alerts. Availability touched a 52-week low of 0.63% earlier in the tracked period and was at 4.2–4.9% as recently as July 2–3. As of July 6, it has partly recovered to 20.5% — meaning roughly one share is available for every five already borrowed. That is still tight, not loose.

Cost to borrow has risen 82% over the past month to 1.26%. The month-long climb signals that demand for borrows has been structural, not episodic.

Options and Analyst Backdrop

The put/call ratio stands at 1.16, near its 52-week high of 1.29. Options positioning has been defensive since late June, when the PCR crossed above 1.0 and stayed there. That reading pre-dated the sell-off.

Analysts have not pulled targets. B of A raised its target to $280 on June 8. The consensus mean target is $244.21 — now above the current share price. Earnings are due July 28. The last print, in May, moved the stock +23% on the day.

Data Summary

• Price: $195.19, -29.3% on the week, -14.3% on the month
• Short interest: 24.0% of free float (July 6), +17.3% over 30 days
• Borrow availability: 20.5% (partly recovered from 4.2% low on July 3)
• Cost to borrow: 1.26%, +82% over 30 days
• Insider net sales (90d): ~$144M; CEO sold $11M on July 1
• PCR: 1.16, near the 52-week high of 1.29
• Analyst mean target: $244.21
• Next earnings: July 28